Business
License and Development Agreement
License and Development Agreement.
About this update from Tekcapital Plc
[{"type":"text","content":"\n \nRNS Number : 9933X Tekcapital plc 28 February 2017 \n\n \nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (\"MAR\"). With the publication of this announcement via a Regulatory Information Service (\"RIS\"), this inside information is now considered to be in the public domain.\n \n \n28 February 2017\nTekcapital plc\n(\"Tekcapital\" or the \"Company\")\n \nBELLUSCURA LTD ANNOUNCES OXYGEN CONCENTRATOR LICENSE AND DEVELOPMENT AGREEMENT\n \nTekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Ltd (\"Belluscura\") has signed a co-exclusive license and development agreement with Separation Design Group (\"SDG\") to develop a next generation portable oxygen concentrator (\"POC\"). As part of the agreement, Belluscura has licensed a portfolio of six intellectual properties from SDG1 and has agreed to provide monthly funding towards the development of a prototype POC device. \n \nA POC is a device used to deliver concentrated oxygen to a patient requiring oxygen therapy. POCs are typically prescribed to people suffering from chronic obstructive pulmonary disease (\"COPD\"). The World Health Organization has estimated that 64 million people are suffering from moderate to severe COPD around the world2. POCs are generally considered a safer, less expensive and more convenient treatment for COPD compared to traditional compressed oxygen cylinders3. Ambulatory patients can benefit from greater personal freedom, with most airlines permitting their use during flight. The US Federal Aviation Authority requires all airlines landing in the USA to permit the use of approved POCs4.\n \nSDG is a leading research laboratory in the field of oxygen concentrators. The Directors believe that the license should allow Belluscura to access and develop a next generation POC based on SDG's significant intellectual property portfolio, covering such features as oxygen enrichment, portability, oxygen conditioning and convenient and cost-effective maintenance. \nBob Rauker, Belluscura's CEO said: \"We are delighted to enter into this license and development agreement. With the ...